256 related articles for article (PubMed ID: 12113071)
21. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
[TBL] [Abstract][Full Text] [Related]
22. [The role of the preoperative radiochemotherapy and the role of neoadjuvant chemotherapy before radical Wertheim-Meigs hysterectomy for cervical cancer stage I B - II B].
Ivanov S; Kŭrlov A
Akush Ginekol (Sofiia); 2006; 45(2):28-31. PubMed ID: 16637300
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy in the primary treatment of cervical carcinoma.
Serkies K; Jassem J
Crit Rev Oncol Hematol; 2005 Jun; 54(3):197-208. PubMed ID: 15890269
[TBL] [Abstract][Full Text] [Related]
24. [Adjuncts to surgery in cervical cancer].
Serkies K; Wegrzynowicz E; Jassem J
Przegl Lek; 2005; 62(12):1460-4. PubMed ID: 16786773
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report.
Plante M; Lau S; Brydon L; Swenerton K; LeBlanc R; Roy M
Gynecol Oncol; 2006 May; 101(2):367-70. PubMed ID: 16542714
[TBL] [Abstract][Full Text] [Related]
26. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
Kornovski Y; Gorchev G
J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
[TBL] [Abstract][Full Text] [Related]
27. Operative management of cervical cancer.
Dreyer G
Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):563-76. PubMed ID: 16150394
[TBL] [Abstract][Full Text] [Related]
28. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
[TBL] [Abstract][Full Text] [Related]
29. Do we need a new classification for radical hysterectomy? Insights in surgical anatomy and local tumor spread from human embryology.
Höckel M
Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S106-12. PubMed ID: 17727931
[TBL] [Abstract][Full Text] [Related]
30. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin.
Takekuma M; Hirashima Y; Takahashi N; Yamamichi G; Furukawa N; Yamada Y; Takakuwa R; Ito I
Anticancer Drugs; 2006 Jul; 17(6):715-8. PubMed ID: 16917218
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B-2B cervical cancer.
Bae JH; Lee SJ; Lee A; Park YG; Bae SN; Park JS; Namkoong SE
Gynecol Oncol; 2008 Dec; 111(3):444-8. PubMed ID: 18829085
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
33. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
[TBL] [Abstract][Full Text] [Related]
34. [Assessment of effectiveness of preoperative chemoradiotherapy in patients with T1B-2ABN0-1M0 cervical cancer].
Baranov SB; Guseĭnov KD
Vopr Onkol; 2003; 49(5):612-4. PubMed ID: 14682134
[TBL] [Abstract][Full Text] [Related]
35. Clinical aspects of multimodality therapy for resectable locoregional esophageal cancer.
Shinoda M; Hatooka S; Mori S; Mitsudomi T
Ann Thorac Cardiovasc Surg; 2006 Aug; 12(4):234-41. PubMed ID: 16977291
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
[TBL] [Abstract][Full Text] [Related]
37. Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer).
Classe JM; Rauch P; Rodier JF; Morice P; Stoeckle E; Lasry S; Houvenaeghel G;
Gynecol Oncol; 2006 Sep; 102(3):523-9. PubMed ID: 16504274
[TBL] [Abstract][Full Text] [Related]
38. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D
Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669
[TBL] [Abstract][Full Text] [Related]
39. Robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer.
Vizza E; Patrizi L; Saltari M; Sindico S; Cimino M; Corrado G
Minim Invasive Ther Allied Technol; 2012 May; 21(3):206-9. PubMed ID: 22554031
[TBL] [Abstract][Full Text] [Related]
40. Chemoradiation in cervical carcinoma: a must?
Cellini N; Morganti AG; Macchia G; Valentini V; Luzi S; Smaniotto D
Expert Rev Anticancer Ther; 2002 Feb; 2(1):83-9. PubMed ID: 12113072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
